Molecular dimensions of the substrate binding site of cytochrome P-448.
暂无分享,去创建一个
D. Lewis | C. Ioannides | D. Parke | C Ioannides | D V Parke | D F Lewis | D. Lewis | Costas Ioannides | D. V. Parke
[1] O. Gotoh,et al. Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat. , 1985, The Journal of biological chemistry.
[2] A. Y. Lu,et al. Aldrin epoxidation catalyzed by purified rat-liver cytochromes P-450 and P-448. High selectivity for cytochrome P-450. , 1980, European journal of biochemistry.
[3] T. Kamataki,et al. Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P-450. , 1981, Chemico-biological interactions.
[4] J. Vialle,et al. THE CRYSTAL STRUCTURE OF MORPHINE HYDRATE , 1976 .
[5] T. Kamataki,et al. Metabolic activation of mutagenic tryptophan pyrolysis products (Trp-P-1 and Trp-P-2) by a purified cytochrome P-450-dependent monooxygenase system. , 1980, Cancer letters.
[6] P. Thomas,et al. Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.
[7] F. Guengerich,et al. Selectivity of 1-phenylimidazole as a ligand for cytochrome P-450 and as an inhibitor of microsomal oxidation. , 1983, Biochemical pharmacology.
[8] H. Yonekawa,et al. Participation of the microsomal electron transport system in mutagenic activation of 4-dimethylaminoazobenzene, 4-methylaminoazobenzene and their 3'-methyl-derivatives. , 1982, Biochemical and biophysical research communications.
[9] N. Harada,et al. Purification and characterization of four forms of cytochrome P-450 from liver microsomes of phenobarbital-treated and 3-methylcholanthrene-treated rats. , 1984, Journal of biochemistry.
[10] H. A. Masson,et al. The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test. , 1983, Carcinogenesis.
[11] Induction of different species of cytochrome P-450 by coplanar and noncoplanar isomers of hexachlorobiphenyl. , 1980, Life sciences.
[12] T. Orton,et al. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). , 1982, The Biochemical journal.
[13] C. Ioannides,et al. Inhibition of cytochrome P-448 mixed function oxidase activity following administration of 9-hydroxyellipticine to rats. , 1980, Chemico-biological interactions.
[14] C. Ioannides,et al. Foetal and neonatal development of cytochrome P-450 and cytochrome P-448 catalysed mixed function oxidases in the rat: induction by 3-methylcholanthrene. , 1985, Toxicology.
[15] J. J. H. McDowell,et al. The crystal and molecular structure of chlorpromazine , 1969 .
[16] Michael J. S. Dewar,et al. Ground states of molecules. XXV. MINDO/3. Improved version of the MINDO semiempirical SCF-MO method , 1975 .
[17] T. Kamataki,et al. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver. , 1980, Cancer research.
[18] A. J. Ryan,et al. The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds. , 1983, Chemico-biological interactions.
[19] W. Parsons,et al. Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. , 1977, Life sciences.
[20] P. Thomas,et al. Use of monoclonal antibody probes against rat hepatic cytochromes P-450c and P-450d to detect immunochemically related isozymes in liver microsomes from different species. , 1984, Archives of biochemistry and biophysics.
[21] M. Ingelman-Sundberg,et al. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. , 1984, The Journal of biological chemistry.
[22] J. Leger,et al. Structure cristalline du chlorhydrate de propranolol dextrogyre , 1975 .
[23] P. Thomas,et al. Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene. , 1979, The Journal of biological chemistry.
[24] D. Parke. Survey of drug-metabolizing enzymes. , 1983, Biochemical Society transactions.
[25] A. Camerman,et al. The stereochemical basis of anticonvulsant drug action. I. The crystal and molecular structure of diphenylhydantoin, a noncentrosymmetric structure solved by centric symbolic addition , 1971 .
[26] K. Dus. Insights into the active site of the cytochrome P-450 haemoprotein family--a unifying concept based on structural considerations. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.
[27] Nebert Dw,et al. The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. , 1979 .
[28] D. Sutor. The structures of the pyrimidines and purines. VI. The crystal structure of theophylline , 1958 .
[29] A. Y. Lu,et al. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. II. Role of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylations. , 1972, The Journal of biological chemistry.
[30] A. Conney,et al. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. , 1960, The Journal of pharmacology and experimental therapeutics.
[31] M. Suzuki,et al. Induction of hepatic microsomal propranolol N-desisopropylase activity by 3-methylcholanthrene and Sudan III. , 1982, Biochemical and biophysical research communications.
[32] J. Hinson. Reactive metabolites of phenacetin and acetaminophen: a review , 1983, Environmental health perspectives.
[33] J. Bridges,et al. Further studies on the dissociation of the isosafrole metabolite-cytochrome P-450 complex. , 1979, Biochemical pharmacology.
[34] C. Ioannides,et al. The mutagenicity of 9-hydroxyellipticine and its induction of cytochrome P-448 activity in rat liver microsomes. , 1982, Carcinogenesis.
[35] F. Guengerich,et al. Purification and characterization of the major microsomal cytochrome P-450 form induced by trans-stilbene oxide in rat liver. , 1984, Biochimica et biophysica acta.
[36] C. Kennard,et al. Insecticides. Part II. Crystal structures of 1,1-bis-(p-chlorophenyl)-2,2,2-trichloroethane (p,p′-DDT) and 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane (o,p′-DDT) , 1972 .
[37] D. Sutor. The structures of the pyrimidines and purines. VII. The crystal structure of caffeine , 1958 .
[38] C. Ioannides,et al. Determination of cytochrome P-448 activity in biological tissues. , 1984, The Biochemical journal.
[39] A. Y. Lu,et al. Kinetic isotope effects on cytochrome P-450-catalyzed oxidation reactions. The oxidative O-dealkylation of 7-ethoxycoumarin. , 1984, The Journal of biological chemistry.
[40] C. Lieber,et al. NH2-terminal sequence analyses of four rat hepatic microsomal cytochromes P-450. , 1984, Archives of biochemistry and biophysics.
[41] T. Inoue,et al. The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) in vitro in rat. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.
[42] H. L. Carrell,et al. Molecular structures of 5,6- and 7,8-benzoflavones, inhibitors of aryl hydrocarbon hydroxylase. , 1980, Cancer research.
[43] S. Scrimgeour,et al. 3,4‐Benzopyrene (a new refinement) , 1976 .
[44] C. Ioannides,et al. The role of nutrition in toxicology. , 1981, Annual review of nutrition.
[45] C. Ioannides,et al. Studies on the substrate-binding sites of liver microsomal cytochrome P-448. , 1982, The Biochemical journal.
[46] F. Guengerich,et al. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. , 1984, Biochemistry.
[47] Molecular structure of (±) 7α,8β-dihydroxy 9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; an X-ray crystallographic study , 1980 .
[48] D. Nebert,et al. Cytochrome P450 gene expression and regulation , 1985 .
[49] J. Goldstein,et al. Purification and characterization of a second form of hepatic cytochrome P-448 from rats treated with a pure polychlorinated biphenyl isomer. , 1982, The Journal of biological chemistry.
[50] B. Craven. Pseudosymmetry in cholesterol monohydrate , 1979 .
[51] J. Depierre,et al. Metabolism of 2-acetylaminofluorene by eight different forms of cytochrome P-450 isolated from rat liver. , 1985, Carcinogenesis.
[52] A. Y. Lu,et al. Role of Purified Cytochrome P-448 and Epoxide Hydrase in the Activation and Detoxification of Benzo[a]pyrene , 1977 .
[53] C. Ioannides,et al. Inhibition of rat hepatic mixed function oxidases by antimalarial drugs: selectivity for cytochromes P-450 and P-448. , 1984, Chemico-biological interactions.
[54] C. Ioannides,et al. Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450. , 1981, Food and cosmetics toxicology.
[55] F. Guengerich,et al. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine. , 1984, Cancer research.
[56] C. Ioannides,et al. Cytochrome P-448 and the activation of toxic chemicals and carcinogens. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.
[57] P. Thomas,et al. Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. , 1983, The Journal of biological chemistry.
[58] T. Cresteil,et al. Enzymatic and immunological characterization of cytochromes P 450 from ellipticine-treated rat liver. , 1982, Biochemical and biophysical research communications.
[59] P. Thomas,et al. Purification and characterization of a minor form of hepatic microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls☆ , 1982 .
[60] Eric F. Johnson,et al. The role of cytochrome P-450 forms in 2-aminoanthracene and benz[α]pyrene mutagenesis , 1979 .
[61] A. F. Peerdeman,et al. The Crystal Structures of Aflatoxin B1. II. The Structure of an Orthorhombic and a Monoclinic Modification , 1970 .
[62] C. Courseille,et al. Structure cristalline et moléculaire de la quinacrine , 1973 .
[63] F. Guengerich,et al. Induction of cytochrome P-450 mRNAs quantitated by in vitro translation and immunoprecipitation. , 1984, Archives of biochemistry and biophysics.
[64] S. Lohmann,et al. Theophylline metabolism by the rat liver microsomal system. , 1976, The Journal of pharmacology and experimental therapeutics.
[65] J. Cumps,et al. Metyrapone - reduced cytochrome P-450 complex: a specific method for the determination of the phenobarbital inducible form of rat hepatic microsomal cytochrome P-450. , 1980, Biochemical and biophysical research communications.
[66] H V Gelboin,et al. Expression of cytochromes P-450 in rat hepatoma cells. Analysis by monoclonal antibodies specific for cytochromes P-450 from rat liver induced by 3-methylcholanthrene or phenobarbital. , 1984, European journal of biochemistry.
[67] J. Maxwell,et al. Folate Deficiency after Anticonvulsant Drugs: An Effect of Hepatic Enzyme Induction? , 1972, British medical journal.
[68] J. McDowell. The Crystal and Molecular Structure of Phenothiazine , 1976 .